The New England Journal of Medicine has published results from the Phase II eNRGy trial for Bizengri (zenocutuzumab), a novel cancer med from Merus. Bizengri is the first approved treatment for people ...
US clinical-stage biotech Qlaris Bio has announced positive top-line results from two U.S. Phase II clinical trials ...
Warren Buffett Just Added $610 Million Worth of These 3 Stocks to Berkshire Hathaway's Portfolio. Here's the Best of the ...
Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...
HelloHero, a leading provider of technology-powered mental health and behavioral care, has secured a multi-million dollar investment package from Decathlon Capital Partners. The funding will enable ...
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced the 2025 ...
LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...
The United States Postal Service on Wednrsday said it would start accepting packages from China and Hong Kong again, just ...
The US Postal Service on Wednesday morning announced it will continue accepting incoming international parcels from China and ...
Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...
Move followed US introduction of tariffs on Chinese imports and removal of long-standing duty-exemption rule, but is no ...
Salesforce poached its newest senior executive hire from within its own house, hiring the board’s lead independent director ...